Related Experiment Video
Updated: Aug 17, 2026
Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
Published on: August 16, 2016
Uptake of catecholamines by human cardiac muscle in vitro
Insights
Heart muscle noradrenaline uptake is reduced in heart failure. This uptake is inhibited by increased noradrenaline levels and specific drugs like desmethylimipramine and amitriptyline.
Area of Science:
- Cardiology
- Pharmacology
- Molecular Biology
Background:
- Noradrenaline is a key neurotransmitter in cardiac function.
- Understanding noradrenaline uptake mechanisms is crucial for managing heart conditions.
Purpose of the Study:
- To investigate noradrenaline uptake in human heart muscle.
- To assess factors affecting noradrenaline uptake in cardiac patients.
Main Methods:
- Studied noradrenaline uptake in right atrial muscle from 102 cardiac surgery patients.
- Incubated tissue with 3H-noradrenaline in Krebs-Henseleit solution.
Main Results:
- Noradrenaline uptake was significantly lower in failing heart muscle.
- Uptake inhibition observed with increased noradrenaline concentration.
- Desmethylimipramine, amitriptyline, and ouabain inhibited noradrenaline uptake.
Conclusions:
- Failing heart muscle exhibits impaired noradrenaline uptake.
- Specific drugs and substrate concentration modulate cardiac noradrenaline uptake.
Abstract:
Noradrenaline uptake was studied using heart muscle from 102 patients undergoing cardiac surgery. Slices of right atrium were incubated in Krebs-Henseleit solution containing 1.3 x 10(-7) M 3H-noradrenaline. Uptake was lower in failing heart muscle and was inhibited not only by increasing the noradrenaline concentration in the incubating medium but also by adding the drugs desmethylimipramine, amitryptyline, and ouabain.
